Please enable JS

YOU ARE

A SPONSOR / CRO

Success is when the time to access an innovative treatment is reduced.

Get more informations

Optimize patient recruitment for your clinical trials

By providing CT-SCOUT™ to your clinical sites you will both facilitate their contribution to your studies and get a better overview of the site recruitment activities for your studies. You can also further enlarge your patient reach by providing ToTem4me to referral sites, with no need to train them on your studies.

THE PATIENT JOURNEY

Telemedicine Technologies favors direct contact with patients (with the medical team via ct-scout) and (with an expert clinical trial coordinator via ToTem4me) to involve them wherever they are and empower them to make the decision to participate in a clinical trial.

Through a questionnaire based on a powerful and reliable algorithm, you can pre-select qualified patients for your trial.

A coordinator is made available to the patient following registration on ToTem4me to follow up with the patient before, during and after inclusion in a clinical trial. A notification is sent to the clinical research team once a pest has been detected on CT-SCOUT™.

Get more information

Looking for innovative digital solutions to optimize patient recruitment in IBD trials

Read the post

Testimonials

« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress Prof Laurent Peyrin-Biroulet,

Prof Laurent Peyrin-Biroulet
President, GETAID and ECCO

« CT-SCOUT™ represents a true added value to clinical research. It takes only few minutes to operate and study information is updated very quickly »

Prof Stéphane Nancey
Hepato-gastroenterology department,
Lyon-Sud University Hospital

« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress Prof Laurent Peyrin-Biroulet,

Prof Laurent Peyrin-Biroulet
President, GETAID and ECCO

LATEST NEWSOUR NEWS >

telemedecine technologies news

Building Confidence in Clinical Trial Data and Technology Processes

March 31, 2026

Applied Clinical Trials Online Clinical trials are growing more complex, and this trend will increase. Sponsors now expect seamless data capture from electronic systems, labs, wearables, patient-reported outcomes, and third-party sources, all feeding pivotal datasets. As data sources become more diverse and voluminous, the risk of integration and process errors rises. Small oversights in data […]

READ MORE
telemedecine technologies news

FDA exempts more wearable, AI features from oversight

March 31, 2026

Medtech Dive FDA exempts more wearable, AI features from oversight In a pair of guidance documents, the regulator clarified the types of wellness features and clinical decision support tools that don’t fall under medical device oversight. By: Elise Reuter • Published Jan. 8, 2026 The Food and Drug Administration released two final guidance documents that would […]

READ MORE
telemedecine technologies news

A Proud Moment for Telemedicine Technologies at EUCROF 26

February 26, 2026

During the EUCROF 2026 gala dinner in Amsterdam, in front of 300+ participants from the European clinical research ecosystem, the xShare project Open Call Awards for Clinical Research were officially presented. We are extremely proud that Telemedicine Technologies contributed to three complementary xShare Open Call projects (out of 10), all recognised for their quality, innovation […]

READ MORE